Nordson beats Q3 estimates and raises FY26 guide on electronics-led surge

The quarter cleared both consensus and Nordson’s own high-end guide. Adjusted EPS of $3.25 exceeded the published consensus of approximately $3.09, while sales of $817.7 million topped the roughly $795 million estimate. Sales also came in above the prior $760-$790 million company outlook, and adjusted EPS exceeded the prior $2.95-$3.15 range. The filing says results were “above the high-end of our most recent earnings guidance.” 〔0〕

The quality of growth was better than the headline suggests. Total sales rose 10.3%, with 11.7% organic growth after removing a 1.2% acquisition/divestiture headwind and a 0.2% currency drag (Sales Variance). 〔1〕 Advanced Technology Solutions was the clear upside engine, with sales up 28.4% and EBITDA up 58%, while Medical and Fluid Solutions delivered 11% organic growth excluding the divested business (Segment results).

The beat was broad rather than purely revenue-driven. Gross margin expanded to 55.5%, and total EBITDA margin held at 32% despite Industrial Precision Solutions’ margin falling to 35% from 37%; the mix benefit came from Advanced Technology Solutions’ margin rising to 30% from 24% and Medical and Fluid Solutions remaining at 38% (Income Statement; Segment EBITDA). The quarter did include a $14.9 million non-cash loss on a minority investment, but adjusted EPS still reached a record $3.25.

The more important signal is the second consecutive full-year guide raise. Fiscal 2026 sales guidance moved to $3.035-$3.075 billion from the prior $2.93-$3.01 billion range, while adjusted EPS moved to $11.80-$12.00 from $11.30-$11.80. The new midpoint implies roughly 3% more sales and adjusted EPS than the prior midpoint, placing the outlook above the published full-year EPS estimate of approximately $11.59. The net read is a meaningful beat with improved forward expectations, though the direction of momentum was already partly known after the prior guidance increase.